{"id":54207,"date":"2026-02-23T21:58:59","date_gmt":"2026-02-23T21:58:59","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/bladder-cancer-therapeutics-diagnostics-market-mordor\/"},"modified":"2026-10-02T09:44:29","modified_gmt":"2026-10-02T00:44:29","slug":"bladder-cancer-therapeutics-diagnostics-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/bladder-cancer-therapeutics-diagnostics-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \ubc29\uad11\uc554 \uce58\ub8cc\uc81c \ubc0f \uc9c4\ub2e8 \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2026-2031\ub144)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/bladder-cancer-therapeutics-diagnostics-market_1663251006852_2321.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/bladder-cancer-therapeutics-diagnostics-market-size-image-1770803478670.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \uc804 \uc138\uacc4 \ubc29\uad11\uc554 \ubc1c\ubcd1\ub960 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.2 \uba74\uc5ed\uad00\ubb38\uc5b5\uc81c\uc81c \ubc0f ADC\uc758 \uc2e0\uc18d\ud55c \uc2b9\uc778<\/li>\n<li class=\"toc-level-3\">4.2.3 \uccad\uc0c9\uad11 \ubc0f 4K \ubc29\uad11\uacbd \uac80\uc0ac\uc758 \uad11\ubc94\uc704\ud55c \ucc44\ud0dd<\/li>\n<li class=\"toc-level-3\">4.2.4 AI \uae30\ubc18 \uc18c\ubcc0 \ubc14\uc774\uc624\ub9c8\ucee4 \uc54c\uace0\ub9ac\uc998<\/li>\n<li class=\"toc-level-3\">4.2.5 ASC \uae30\ubc18 \ubc29\uad11\uacbd \uac80\uc0ac\ub7c9 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.6 \uc7ac\ucda9\uc804 \uac00\ub2a5\ud55c \ubc29\uad11 \ub0b4 \uc57d\ubb3c \uc804\ub2ec \uc7a5\uce58<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \uc8fc\uc694 \ud654\ud559\uc694\ubc95 \uc57d\ubb3c\uc758 \ud2b9\ud5c8 \ub9cc\ub8cc \ubc0f \uc81c\ub124\ub9ad \uce68\uc2dd<\/li>\n<li class=\"toc-level-3\">4.3.2 \uc2e0\uaddc \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c\uc758 \ub192\uc740 \ube44\uc6a9\/\uc0c1\ud658 \uc7a5\ubcbd<\/li>\n<li class=\"toc-level-3\">4.3.3 \uc804 \uc138\uacc4 BCG \ubd80\uc871\uc73c\ub85c \uc778\ud55c \uce58\ub8cc \ud328\ud134 \ud63c\ub780<\/li>\n<li class=\"toc-level-3\">4.3.4 \uc751\uae09 \uc758\ub8cc \uc11c\ube44\uc2a4(EMS)\uc5d0\uc11c \uccad\uc0c9\uad11 \uc7a5\ube44 \uac00\uc6a9\uc131 \uc81c\ud55c<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \uaddc\uc81c \ud658\uacbd<\/li>\n<li class=\"toc-level-2\">4.5 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.5.1 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.5.2 \uad6c\ub9e4\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.5.3 \uacf5\uae09\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.5.4 \ub300\uccb4\uc7ac\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.5.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21 (USD \uac00\uce58)<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \uc81c\ud488\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 \uce58\ub8cc\uc81c<\/li>\n<li class=\"toc-level-4\">5.1.1.1 \ud654\ud559\uc694\ubc95<\/li>\n<li class=\"toc-level-4\">5.1.1.2 \uba74\uc5ed\uc694\ubc95<\/li>\n<li class=\"toc-level-4\">5.1.1.3 \ud56d\uccb4-\uc57d\ubb3c \uc811\ud569\uccb4<\/li>\n<li class=\"toc-level-4\">5.1.1.4 \ubc29\uad11 \ub0b4 \uc57d\ubb3c \uc804\ub2ec \uc7a5\uce58<\/li>\n<li class=\"toc-level-3\">5.1.2 \uc9c4\ub2e8<\/li>\n<li class=\"toc-level-4\">5.1.2.1 \ubc29\uad11\uacbd \uac80\uc0ac<\/li>\n<li class=\"toc-level-4\">5.1.2.2 \ubc29\uad11 \ucd08\uc74c\ud30c &amp; \uc601\uc0c1<\/li>\n<li class=\"toc-level-4\">5.1.2.3 \uc18c\ubcc0 \uac80\uc0ac &amp; \ub525\uc2a4\ud2f1 \ud14c\uc2a4\ud2b8<\/li>\n<li class=\"toc-level-4\">5.1.2.4 \uc18c\ubcc0 &amp; \uc561\uccb4 \uc0dd\uac80 \ubc14\uc774\uc624\ub9c8\ucee4 \ud328\ub110<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \uc554 \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \uc694\ub85c\uc0c1\ud53c\uc554<\/li>\n<li class=\"toc-level-3\">5.2.2 \ud3b8\ud3c9\uc138\ud3ec\uc554<\/li>\n<li class=\"toc-level-3\">5.2.3 \uc120\uc554 &amp; \uae30\ud0c0 \ud76c\uadc0 \uc720\ud615<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \ubcd1\uc6d0<\/li>\n<li class=\"toc-level-3\">5.3.2 \uc678\ub798 \uc218\uc220 \uc13c\ud130<\/li>\n<li class=\"toc-level-3\">5.3.3 \uc804\ubb38 \uc13c\ud130<\/li>\n<li class=\"toc-level-3\">5.3.4 \ud559\uc220 \ubc0f \uc5f0\uad6c \uae30\uad00<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.4.1 \ubd81\ubbf8<\/li>\n<li class=\"toc-level-4\">5.4.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.4.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.4.1.3 \uba55\uc2dc\ucf54<\/li>\n<li class=\"toc-level-3\">5.4.2 \uc720\ub7fd<\/li>\n<li class=\"toc-level-4\">5.4.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.4.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.4.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.4.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.4.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.4.2.6 \uae30\ud0c0 \uc720\ub7fd<\/li>\n<li class=\"toc-level-3\">5.4.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-4\">5.4.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.4.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.4.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.4.3.4 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.4.3.5 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.4.3.6 \uae30\ud0c0 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-3\">5.4.4 \uc911\ub3d9 &amp; \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.4.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.4.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.4.4.3 \uae30\ud0c0 \uc911\ub3d9 &amp; \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-3\">5.4.5 \ub0a8\ubbf8<\/li>\n<li class=\"toc-level-4\">5.4.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.4.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.4.5.3 \uae30\ud0c0 \ub0a8\ubbf8<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/li>\n<li class=\"toc-level-2\">6.2 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">6.3 \uae30\uc5c5 \ud504\ub85c\ud544 (\uae00\ub85c\ubc8c \uac1c\uc694, \uc2dc\uc7a5 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34, \uc804\ub7b5 \uc815\ubcf4, \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 \ubc0f \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ud3ec\ud568)\n<ul>\n<li class=\"toc-level-3\">6.3.1 F. Hoffmann-La Roche Ltd<\/li>\n<li class=\"toc-level-3\">6.3.2 Merck &amp; Co. Inc.<\/li>\n<li class=\"toc-level-3\">6.3.3 Bristol-Myers Squibb Company<\/li>\n<li class=\"toc-level-3\">6.3.4 Pfizer Inc.<\/li>\n<li class=\"toc-level-3\">6.3.5 Johnson &amp; Johnson (Janssen)<\/li>\n<li class=\"toc-level-3\">6.3.6 Novartis AG<\/li>\n<li class=\"toc-level-3\">6.3.7 AstraZeneca PLC<\/li>\n<li class=\"toc-level-3\">6.3.8 GlaxoSmithKline PLC<\/li>\n<li class=\"toc-level-3\">6.3.9 Astellas Pharma Inc.<\/li>\n<li class=\"toc-level-3\">6.3.10 Abbott Laboratories<\/li>\n<li class=\"toc-level-3\">6.3.11 Olympus Corporation<\/li>\n<li class=\"toc-level-3\">6.3.12 Pacific Edge Ltd (Cxbladder)<\/li>\n<li class=\"toc-level-3\">6.3.13 UroGen Pharma Ltd<\/li>\n<li class=\"toc-level-3\">6.3.14 CG Oncology<\/li>\n<li class=\"toc-level-3\">6.3.15 ImmunityBio Inc.<\/li>\n<li class=\"toc-level-3\">6.3.16 Teleflex Inc.<\/li>\n<li class=\"toc-level-3\">6.3.17 Boston Scientific Corp.<\/li>\n<li class=\"toc-level-3\">6.3.18 Coloplast A\/S<\/li>\n<li class=\"toc-level-3\">6.3.19 Endo International plc<\/li>\n<li class=\"toc-level-3\">6.3.20 Ameritech Diagnostic Reagent (Jiaxing) Co.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\ubc29\uad11\uc554 \uce58\ub8cc\uc81c \ubc0f \uc9c4\ub2e8 \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d: \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f 2031\ub144 \uc804\ub9dd<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0\uc758 \ubc29\uad11\uc554 \uce58\ub8cc\uc81c \ubc0f \uc9c4\ub2e8 \uc2dc\uc7a5\uc5d0 \ub300\ud55c \uc2ec\uce35\uc801\uc778 \ubd84\uc11d\uc744 \uc81c\uacf5\ud558\uba70, \uc2dc\uc7a5 \uaddc\ubaa8, \uc131\uc7a5 \ub3d9\ud5a5, \uc8fc\uc694 \ub3d9\uc778 \ubc0f \uc81c\uc57d \uc694\uc778, \uc138\uadf8\uba3c\ud2b8\ubcc4 \ubd84\uc11d, \uc9c0\uc5ed\ubcc4 \ud1b5\ucc30\ub825 \ubc0f \uacbd\uc7c1 \ud658\uacbd\uc744 \uc0c1\uc138\ud788 \ub2e4\ub8f9\ub2c8\ub2e4.<\/p>\n<p>1. \uc2dc\uc7a5 \uac1c\uc694 \ubc0f \uc8fc\uc694 \uc218\uce58<\/p>\n<p>\ubc29\uad11\uc554 \uce58\ub8cc\uc81c \ubc0f \uc9c4\ub2e8 \uc2dc\uc7a5\uc740 2026\ub144\uc5d0 52\uc5b5 2\ucc9c\ub9cc \ub2ec\ub7ec\ub85c \ucd94\uc815\ub418\uba70, 2025\ub144 49\uc5b5 2\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0\uc11c \uc131\uc7a5\ud558\uc5ec 2031\ub144\uc5d0\ub294 70\uc5b5 3\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0 \uc774\ub97c \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc608\uce21 \uae30\uac04(2026-2031\ub144) \ub3d9\uc548 \uc5f0\ud3c9\uade0 6.12%\uc758 \uacac\uace0\ud55c \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>*   \uc5f0\uad6c \uae30\uac04: 2020 &#8211; 2031\ub144<br \/>\n*   2026\ub144 \uc2dc\uc7a5 \uaddc\ubaa8: 52\uc5b5 2\ucc9c\ub9cc \ub2ec\ub7ec<br \/>\n*   2031\ub144 \uc2dc\uc7a5 \uaddc\ubaa8: 70\uc5b5 3\ucc9c\ub9cc \ub2ec\ub7ec<br \/>\n*   \uc131\uc7a5\ub960 (2026-2031\ub144): 6.12% (\uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960)<br \/>\n*   \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc2dc\uc7a5: \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<br \/>\n*   \uac00\uc7a5 \ud070 \uc2dc\uc7a5: \ubd81\ubbf8<br \/>\n*   \uc2dc\uc7a5 \uc9d1\uc911\ub3c4: \uc911\uac04<\/p>\n<p>\uc774\ub7ec\ud55c \uc131\uc7a5\uc740 \uae30\uc874 \ud654\ud559\uc694\ubc95\uc5d0\uc11c \uc815\ubc00 \uba74\uc5ed\uc694\ubc95\uc73c\ub85c\uc758 \uad6c\uc870\uc801 \uc804\ud658\uc744 \ubc18\uc601\ud558\uba70, \uba74\uc5ed\uad00\ubb38\uc5b5\uc81c\uc81c(checkpoint inhibitors) \ubc0f \ud56d\uccb4-\uc57d\ubb3c \uc811\ud569\uccb4(antibody-drug conjugates, ADCs)\uc5d0 \ub300\ud55c \uc2e0\uc18d\ud55c FDA \uc2b9\uc778\uc774 \ubcf5\ud569 \uce58\ub8cc \ud504\ub85c\ud1a0\ucf5c\uc758 \ud575\uc2ec\uc73c\ub85c \uc790\ub9ac \uc7a1\uc73c\uba74\uc11c \uac00\uc18d\ud654\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc804 \uc138\uacc4\uc801\uc73c\ub85c \ubc29\uad11\uc554 \ubc1c\ubcd1\ub960\uc774 \uc99d\uac00\ud558\uace0, \uccad\uc0c9\uad11 \ubc29\uad11\uacbd \uac80\uc0ac\ub97c \ud1b5\ud55c \uc870\uae30 \uc9c4\ub2e8\uc774 \ud655\ub300\ub418\uba70, \uc0c8\ub85c\uc6b4 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c\uc5d0 \ub300\ud55c \ubcf4\ud5d8 \uc801\uc6a9\uc774 \uc9c0\uc6d0\ub418\ub294 \uc810 \ub610\ud55c \uc218\uc694\ub97c \ucd09\uc9c4\ud558\ub294 \uc694\uc778\uc785\ub2c8\ub2e4. \uc0c8\ub85c\uc6b4 \ubc29\uad11 \ub0b4 \uc57d\ubb3c \uc804\ub2ec \uc7a5\uce58\uc640 AI \uae30\ubc18 \uc18c\ubcc0 \ubc14\uc774\uc624\ub9c8\ucee4 \uc54c\uace0\ub9ac\uc998\uc740 \uc784\uc0c1 \uacb0\uacfc\ub97c \uac1c\uc120\ud558\uace0 \ud6c4\uc18d \uad00\ub9ac\ub97c \uac04\uc18c\ud654\ud558\uc5ec \uc785\uc6d0 \ubc0f \uc678\ub798 \ud658\uacbd \ubaa8\ub450\uc5d0\uc11c \uc2dc\uc220\ub7c9\uc744 \uc99d\uac00\uc2dc\ud0a4\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc81c\uc57d \ub300\uae30\uc5c5\ub4e4\uc774 \uc804\ubb38 \uc0dd\uba85\uacf5\ud559 \uae30\uc5c5\uacfc \ud611\ub825\ud558\uc5ec \uce58\ub8cc \ubc0f \uc9c4\ub2e8 \ud601\uc2e0\uc744 \uac00\uce58 \uae30\ubc18 \uc758\ub8cc \uc9c0\ud45c\uc640 \uc5f0\uacc4\ud558\ub824\ub294 \uc6c0\uc9c1\uc784\uc774 \ud65c\ubc1c\ud574\uc9c0\uba74\uc11c \uacbd\uc7c1 \uac15\ub3c4 \ub610\ud55c \uc2ec\ud654\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>2. \uc8fc\uc694 \ubcf4\uace0\uc11c \uc694\uc57d<\/p>\n<p>*   \uc81c\ud488 \uce74\ud14c\uace0\ub9ac\ubcc4: 2025\ub144 \ubc29\uad11\uc554 \uce58\ub8cc\uc81c \ubc0f \uc9c4\ub2e8 \uc2dc\uc7a5\uc5d0\uc11c \uce58\ub8cc\uc81c\uac00 62.10%\uc758 \uc810\uc720\uc728\uc744 \ucc28\uc9c0\ud588\uc73c\uba70, \uba74\uc5ed\uc694\ubc95\uc740 2031\ub144\uae4c\uc9c0 8.25%\uc758 \uac00\uc7a5 \ub192\uc740 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \uc554 \uc720\ud615\ubcc4: 2025\ub144 \ubc29\uad11\uc554 \uce58\ub8cc\uc81c \ubc0f \uc9c4\ub2e8 \uc2dc\uc7a5 \uaddc\ubaa8\uc5d0\uc11c \uc694\ub85c\uc0c1\ud53c\uc554(Urothelial Carcinoma)\uc774 84.10%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, 2031\ub144\uae4c\uc9c0 9.00%\uc758 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\ub85c \ud655\ub300\ub420 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<br \/>\n*   \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4: 2025\ub144 \ub9e4\ucd9c\uc5d0\uc11c \ubcd1\uc6d0\uc774 53.70%\ub97c \uc720\uc9c0\ud588\uc73c\uba70, \uc678\ub798 \uc218\uc220 \uc13c\ud130(Ambulatory Surgical Centers, ASCs)\ub294 \uc804\ub9dd \uae30\uac04 \ub3d9\uc548 7.65%\uc758 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uce21\ub429\ub2c8\ub2e4.<br \/>\n*   \uc9c0\uc5ed\ubcc4: 2025\ub144 \ub9e4\ucd9c\uc5d0\uc11c \ubd81\ubbf8\uac00 44.20%\ub85c \uc120\ub450\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591\uc740 2031\ub144\uae4c\uc9c0 10.40%\uc758 \uac00\uc7a5 \ube60\ub978 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>3. \uae00\ub85c\ubc8c \ubc29\uad11\uc554 \uce58\ub8cc\uc81c \ubc0f \uc9c4\ub2e8 \uc2dc\uc7a5 \ub3d9\ud5a5 \ubc0f \ud1b5\ucc30\ub825<\/p>\n<p>3.1. \uc2dc\uc7a5 \uc131\uc7a5 \ub3d9\uc778<\/p>\n<p>*   \uc804 \uc138\uacc4 \ubc29\uad11\uc554 \ubc1c\ubcd1\ub960 \uc99d\uac00 (+1.5% CAGR \uc601\ud5a5): \uace0\ub839\ud654 \uc778\uad6c \uc99d\uac00\uc640 \uc9c1\uc5c5\uc131 \ubc1c\uc554 \ubb3c\uc9c8 \ub178\ucd9c \uc9c0\uc18d\uc73c\ub85c \ubc1c\ubcd1\ub960\uc774 \uafb8\uc900\ud788 \uc99d\uac00\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. 65\uc138 \uc774\uc0c1 \uc778\uad6c\uc5d0\uc11c \uafb8\uc900\ud55c \uc99d\uac00\uc138\uac00 \ub098\ud0c0\ub098 \uc9c4\ub2e8 \uac10\uc2dc \ubc0f \ub2e4\uc911 \uce58\ub8cc\ubc95\uc5d0 \ub300\ud55c \uc218\uc694\uac00 \ub192\uc544\uc9c0\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc601\uc0c1 \ubc0f \uc18c\ubcc0 \uae30\ubc18 \uac80\uc0ac\ub97c \ud1b5\ud55c \uc870\uae30 \ubc1c\uacac\uc740 \ud2b9\ud788 \ube44\uadfc\uce68\uc724\uc131 \uc9c8\ud658\uc758 \uce58\ub8cc \ub300\uc0c1 \ud658\uc790\uad70\uc744 \ud655\ub300\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub192\uc740 \uc7ac\ubc1c\ub960\uacfc \uad00\ub828\ub41c \ubc18\ubcf5\uc801\uc778 \uac1c\uc785\uc73c\ub85c \uc778\ud574 \ubc29\uad11\uacbd \uc7a5\ube44, \uc18c\ubaa8\ud488 \ubc0f \ubcf4\uc870 \uc694\ubc95\uc5d0 \ub300\ud55c \uc9c0\uc18d\uc801\uc778 \ub9e4\ucd9c\uc774 \ubc1c\uc0dd\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uba74\uc5ed\uad00\ubb38\uc5b5\uc81c\uc81c \ubc0f ADCs\uc758 \uc2e0\uc18d\ud55c \uc2b9\uc778 (+1.8% CAGR \uc601\ud5a5): \uac00\uc18d\ud654\ub41c \uaddc\uc81c \uacbd\ub85c\ub294 \uc2e0\uc57d \uac1c\ubc1c \uc8fc\uae30\ub97c \ub2e8\ucd95\ud558\uace0 \ud658\uc790\ub4e4\uc774 \uc0c8\ub85c\uc6b4 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c\uc5d0 \ub354 \ube68\ub9ac \uc811\uadfc\ud560 \uc218 \uc788\ub3c4\ub85d \ud569\ub2c8\ub2e4. \uc5d4\ud3ec\ub974\ud22c\ub9d9 \ubca0\ub3c4\ud2f4(enfortumab vedotin) \ubc0f \ub354\ubc1c\ub8e8\ub9d9(durvalumab)\uacfc \uac19\uc740 \uc57d\ubb3c\uc740 FDA\ub85c\ubd80\ud130 \ud601\uc2e0 \uce58\ub8cc\uc81c \uc9c0\uc815\uc744 \ubc1b\uc544 \uc8fc\uc694 \uc784\uc0c1 \uc2dc\ud5d8 \ud6c4 5\ub144 \uc774\ub0b4\uc5d0 \uc0c1\uc5c5\uc801 \ucd9c\uc2dc\uac00 \uac00\ub2a5\ud574\uc84c\uc2b5\ub2c8\ub2e4. \ud3a8\ube0c\ub864\ub9ac\uc8fc\ub9d9(pembrolizumab)\uacfc \uc5d4\ud3ec\ub974\ud22c\ub9d9 \ubca0\ub3c4\ud2f4\uc758 \ubcd1\uc6a9 \uc694\ubc95\uc740 \ud654\ud559\uc694\ubc95\uc758 15.9\uac1c\uc6d4 \ub300\ube44 33.8\uac1c\uc6d4\uc758 \uc911\uc559 \uc804\uccb4 \uc0dd\uc874\uc728\uc744 \ub2ec\uc131\ud558\ub294 \ub4f1 \uc124\ub4dd\ub825 \uc788\ub294 \uc0dd\uc874\uc728 \uac1c\uc120\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4.<br \/>\n*   \uccad\uc0c9\uad11 \ubc0f 4K \ubc29\uad11\uacbd \uac80\uc0ac\uc758 \uad11\ubc94\uc704\ud55c \ucc44\ud0dd (+1.2% CAGR \uc601\ud5a5): \ud5a5\uc0c1\ub41c \uc2dc\uac01\ud654 \uae30\uc220\uc740 \ubc31\uc0c9\uad11 \ubc29\uad11\uacbd\uc73c\ub85c\ub294 \ub193\uce58\uae30 \uc26c\uc6b4 \ud3c9\ud3c9\ud558\uace0 \ub2e4\ubc1c\uc131 \ubcd1\ubcc0\uc744 \ubc1c\uacac\ud558\uc5ec \uc9c4\ub2e8 \uc815\ud655\ub3c4\ub97c \ub192\uc785\ub2c8\ub2e4. 2024\ub144 \uba54\ub514\ucf00\uc5b4(Medicare)\uc758 \ubcf4\ud5d8 \uc801\uc6a9 \uacb0\uc815\uc740 \ube44\uc6a9 \uc7a5\ubcbd\uc744 \uc81c\uac70\ud558\uc5ec \uc678\ub798 \uc11c\ube44\uc2a4 \ucc44\ud0dd\uc744 \ucd09\uc9c4\ud588\uc2b5\ub2c8\ub2e4. 4K \uc601\uc0c1\uacfc\uc758 \ud1b5\ud569\uc740 \uc808\uc81c\uc220 \uc911 \uc120\uba85\ub3c4\ub97c \ub192\uc5ec \uc7ac\ubc1c \ubc0f \uc7ac\uc218\uc220\ub960\uc744 \ub0ae\ucda5\ub2c8\ub2e4. \uc678\ub798 \uc218\uc220 \uc13c\ud130\ub294 \uc9e7\uc740 \ud68c\uc804\uc728\uc744 \ud65c\uc6a9\ud558\uc5ec \uc120\ud0dd\uc801 \ubc29\uad11\uacbd \uac80\uc0ac\ub7c9\uc744 \ud761\uc218\ud558\uba70, \ubcd1\uc6d0 \uc678\ubd80\ub85c \ubc29\uad11\uc554 \uce58\ub8cc\uc81c \ubc0f \uc9c4\ub2e8 \uc2dc\uc7a5\uc744 \ud655\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   AI \uae30\ubc18 \uc18c\ubcc0 \ubc14\uc774\uc624\ub9c8\ucee4 \uc54c\uace0\ub9ac\uc998 (+0.9% CAGR \uc601\ud5a5): \uba38\uc2e0\ub7ec\ub2dd \ud50c\ub7ab\ud3fc\uc740 \uc138\ud3ec\uc9c4 \uac80\uc0ac, \ub2e8\ubc31\uc9c8 \ub9c8\ucee4 \ubc0f \uc720\uc804\uccb4 \uc2dc\uadf8\ub2c8\ucc98\ub97c \uacb0\ud569\ud558\uc5ec \uac80\uc99d \uc5f0\uad6c\uc5d0\uc11c 90%\uc5d0 \uac00\uae4c\uc6b4 \ubbfc\uac10\ub3c4\ub85c \uc545\uc131 \uc138\ud3ec\ub97c \uc2dd\ubcc4\ud569\ub2c8\ub2e4. \ud074\ub77c\uc6b0\ub4dc \uae30\ubc18 \ubd84\uc11d\uc740 \uc2e4\ud5d8\uc2e4 \uac04 \ud574\uc11d\uc744 \ud45c\uc900\ud654\ud558\uc5ec \uc6b4\uc601\uc790 \ubcc0\ub3d9\uc131\uc744 \uc904\uc785\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uac80\uc0ac\ub294 \uac10\uc2dc \ud504\ub85c\ud1a0\ucf5c\uc5d0\uc11c \uce68\uc2b5\uc801\uc778 \ubc29\uad11\uacbd \uac80\uc0ac\ub97c \ubd80\ubd84\uc801\uc73c\ub85c \ub300\uccb4\ud558\uc5ec \ud658\uc790 \uc21c\uc751\ub3c4\ub97c \ub192\uc774\uace0 \uc2dc\uc220 \uad00\ub828 \uc774\ud658\uc728\uc744 \uc904\uc77c \uc218 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   ASC \uae30\ubc18 \ubc29\uad11\uacbd \uac80\uc0ac\ub7c9 \uc99d\uac00 (+0.7% CAGR \uc601\ud5a5): \uc678\ub798 \uc218\uc220 \uc13c\ud130(ASCs)\ub294 \ub9ce\uc740 \ubc29\uad11\uacbd \uae30\ubc18 \uc2dc\uc220\uc758 \uc808\ucc28 \uc2dc\uac04\uc774 2\uc2dc\uac04 \ubbf8\ub9cc\uc73c\ub85c \ub2e8\ucd95\ub418\uace0 \ubcf4\ud5d8 \uc801\uc6a9\uc774 \ud655\ub300\ub418\uba74\uc11c \ube60\ub974\uac8c \uc131\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. ASC\ub294 \uc77c\uc815\uc744 \ucd5c\uc801\ud654\ud558\uace0 \uc785\uc6d0 \ubcd1\uc0c1 \uc218\uc694\ub97c \uc904\uc5ec \ub0ae\uc740 \uc2dc\uc124 \ube44\uc6a9\uacfc \uc9e7\uc740 \ud68c\ubcf5 \uc2dc\uac04\uc744 \ud1b5\ud574 \uc9c0\ubd88\uc790\uc640 \ud658\uc790 \ubaa8\ub450\uc5d0\uac8c \uc774\uc810\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<br \/>\n*   \uc7ac\ucda9\uc804 \uac00\ub2a5\ud55c \ubc29\uad11 \ub0b4 \uc57d\ubb3c \uc804\ub2ec \uc7a5\uce58 (+0.6% CAGR \uc601\ud5a5): TAR-200 \ubc0f UGN-102\uc640 \uac19\uc740 \ubc29\uad11 \ub0b4 \uc57d\ubb3c \uc804\ub2ec \ud50c\ub7ab\ud3fc\uc740 \ud654\ud559\uc694\ubc95\uc81c\ub97c \ubc29\uad11\ubcbd\uc5d0 \uc9c1\uc811 \ubc29\ucd9c\ud558\uc5ec \uc804\uc2e0 \ub178\ucd9c\uc744 \uc904\uc774\uba74\uc11c \ud6a8\ub2a5\uc744 \uc720\uc9c0\ud568\uc73c\ub85c\uc368 \uc8fc\ubaa9\ubc1b\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>3.2. \uc2dc\uc7a5 \uc81c\uc57d \uc694\uc778<\/p>\n<p>*   \uc8fc\uc694 \ud654\ud559\uc694\ubc95\uc81c\uc758 \ud2b9\ud5c8 \ub9cc\ub8cc \ubc0f \uc81c\ub124\ub9ad \uce68\uc2dd (-0.8% CAGR \uc601\ud5a5): \ubbf8\ud1a0\ub9c8\uc774\uc2e0 C(mitomycin C) \ubc0f \uc2dc\uc2a4\ud50c\ub77c\ud2f4(cisplatin) \ud2b9\ud5c8 \ub9cc\ub8cc\ub294 \uc81c\ub124\ub9ad \uacbd\uc7c1\uc744 \uc720\ubc1c\ud558\uc5ec \uce58\ub8cc \ub9c8\uc9c4\uc744 \uc555\ubc15\ud569\ub2c8\ub2e4. \uac00\uaca9 \ud558\ub77d\uc740 \uc9c0\ubd88\uc790\uc5d0\uac8c \uc720\ub9ac\ud558\uc9c0\ub9cc, R&#038;D \uc7ac\ud22c\uc790\uc5d0 \ud544\uc694\ud55c \uc81c\uc870\uc5c5\uccb4 \uc218\uc775\uc744 \uc81c\ud55c\ud569\ub2c8\ub2e4.<br \/>\n*   \uc2e0\uaddc \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c\uc758 \ub192\uc740 \ube44\uc6a9 \ubc0f \ubcf4\ud5d8 \uc801\uc6a9 \uc7a5\ubcbd (-0.6% CAGR \uc601\ud5a5): \uba74\uc5ed\uad00\ubb38\uc5b5\uc81c\uc81c \ubc0f ADCs\ub294 \uc5ec\ub7ec \uc2dc\uc7a5\uc5d0\uc11c 1\ud68c \uce58\ub8cc\ub2f9 10\ub9cc \ub2ec\ub7ec \uc774\uc0c1\uc73c\ub85c \ucc45\uc815\ub418\uc5b4, \uc5ec\ub7ec \uc885\uc591\ud559 \uc6b0\uc120\uc21c\uc704\uc758 \uade0\ud615\uc744 \ub9de\ucdb0\uc57c \ud558\ub294 \uc9c0\ubd88\uc790 \uc608\uc0b0\uc5d0 \ubd80\ub2f4\uc744 \uc90d\ub2c8\ub2e4. \uc911\uc18c\ub4dd \uad6d\uac00\uc5d0\uc11c\ub294 \uc0ac\uc804 \uc2b9\uc778 \ubc0f \ub2e8\uacc4\ubcc4 \uce58\ub8cc \uc694\uac74\uc73c\ub85c \uc778\ud574 \uc811\uadfc\uc131\uc774 \uace0\ub974\uc9c0 \ubabb\ud558\uba70 \uce58\ub8cc \uc2dc\uc791\uc774 \uc9c0\uc5f0\ub429\ub2c8\ub2e4.<br \/>\n*   \uc804 \uc138\uacc4 BCG \ubc31\uc2e0 \ubd80\uc871\uc73c\ub85c \uc778\ud55c \uce58\ub8cc \ud328\ud134 \ud63c\ub780 (-0.5% CAGR \uc601\ud5a5): BCG(Bacillus Calmette-Gu\u00e9rin) \ubc31\uc2e0\uc740 \ube44\uadfc\uce68\uc724\uc131 \ubc29\uad11\uc554 \uce58\ub8cc\uc5d0 \uc911\uc694\ud55c \uc5ed\ud560\uc744 \ud558\uc9c0\ub9cc, \uc804 \uc138\uacc4\uc801\uc778 \uacf5\uae09 \ubd80\uc871\uc740 \uce58\ub8cc \ud328\ud134\uc5d0 \uc2ec\uac01\ud55c \uc601\ud5a5\uc744 \ubbf8\uce58\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc2e0\ud765 \uc2dc\uc7a5\uc5d0\uc11c\uc758 \uccad\uc0c9\uad11 \uc7a5\ube44 \uac00\uc6a9\uc131 \uc81c\ud55c (-0.4% CAGR \uc601\ud5a5): \uc2e0\ud765 \uc2dc\uc7a5 \ubc0f \uc120\uc9c4\uad6d\uc758 \ub18d\ucd0c \uc9c0\uc5ed\uc5d0\uc11c\ub294 \uccad\uc0c9\uad11 \ubc29\uad11\uacbd \uc7a5\ube44\uc758 \uac00\uc6a9\uc131\uc774 \uc81c\ud55c\ub418\uc5b4 \ucca8\ub2e8 \uc9c4\ub2e8 \uae30\uc220\uc758 \ubcf4\uae09\uc744 \uc800\ud574\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>4. \uc138\uadf8\uba3c\ud2b8\ubcc4 \ubd84\uc11d<\/p>\n<p>4.1. \uc81c\ud488\ubcc4: \uce58\ub8cc\uc81c \uc2dc\uc7a5 \uc120\ub3c4, \uc9c4\ub2e8\uc81c \uc2dc\uc7a5 \uae09\uc131\uc7a5<\/p>\n<p>*   \uce58\ub8cc\uc81c: 2025\ub144 \ubc29\uad11\uc554 \uce58\ub8cc\uc81c \ubc0f \uc9c4\ub2e8 \uc2dc\uc7a5 \ub9e4\ucd9c\uc758 62.10%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \uc774\ub294 \uc804\uc2e0 \ubc0f \ubc29\uad11 \ub0b4 \uc57d\ubb3c\uc758 \ubc18\ubcf5 \ud22c\uc5ec \ubc0f \ub192\uc740 \ub2e8\uac00\uc5d0 \uae30\uc778\ud569\ub2c8\ub2e4. \ud3a8\ube0c\ub864\ub9ac\uc8fc\ub9d9, \ub354\ubc1c\ub8e8\ub9d9, \ub2c8\ubcfc\ub8e8\ub9d9(nivolumab)\uc758 \uc801\uc751\uc99d \ud655\ub300\uc5d0 \ud798\uc785\uc5b4 \uba74\uc5ed\uc694\ubc95\ub9cc\uc73c\ub85c 8.25%\uc758 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc5d4\ud3ec\ub974\ud22c\ub9d9 \ubca0\ub3c4\ud2f4\uacfc \uac19\uc740 \ud56d\uccb4-\uc57d\ubb3c \uc811\ud569\uccb4\ub294 \ud2b9\ud788 \ubc31\uae08 \uae30\ubc18 \ud654\ud559\uc694\ubc95\uc5d0 \ubd80\uc801\ud569\ud55c \ud658\uc790\uad70\uc744 \uc704\ud55c \uc0c8\ub85c\uc6b4 \uad6c\uc81c \uacbd\ub85c\ub97c \uc5f4\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc9c4\ub2e8\uc81c: \uccad\uc0c9\uad11 \ubc29\uad11\uacbd, 4K \uc601\uc0c1 \uc7a5\ube44, AI \uae30\ubc18 \uc18c\ubcc0 \uac80\uc0ac \ub4f1 \uc870\uae30 \uc9c4\ub2e8\uc744 \ud5a5\uc0c1\uc2dc\ud0a4\ub294 \uae30\uc220\uc5d0 \ud798\uc785\uc5b4 \uc2dc\uc7a5 \uaddc\ubaa8\uac00 \uc99d\uac00\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. TAR-200 \ubc0f UGN-102\uc640 \uac19\uc740 \ubc29\uad11 \ub0b4 \uc57d\ubb3c \uc804\ub2ec \ud50c\ub7ab\ud3fc\uc740 \ud654\ud559\uc694\ubc95\uc81c\ub97c \ubc29\uad11\ubcbd\uc5d0 \uc9c1\uc811 \ubc29\ucd9c\ud558\uc5ec \uc804\uc2e0 \ub178\ucd9c\uc744 \uc904\uc774\uba74\uc11c \ud6a8\ub2a5\uc744 \uc720\uc9c0\ud568\uc73c\ub85c\uc368 \uc8fc\ubaa9\ubc1b\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>4.2. \uc554 \uc720\ud615\ubcc4: \uc694\ub85c\uc0c1\ud53c\uc554\uc774 \uac1c\ubc1c \ub178\ub825 \uc8fc\ub3c4<\/p>\n<p>*   \uc694\ub85c\uc0c1\ud53c\uc554: 2025\ub144 \ub9e4\ucd9c\uc758 84.10%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, 9.00%\uc758 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uc5b4 \ubc29\uad11\uc554 \uce58\ub8cc\uc81c \ubc0f \uc9c4\ub2e8 \uc2dc\uc7a5\uc5d0\uc11c \uc784\uc0c1 \ud601\uc2e0\uc758 \ud575\uc2ec \ucd08\uc810\uc73c\ub85c\uc11c\uc758 \uc785\uc9c0\ub97c \uad73\ud788\uace0 \uc788\uc2b5\ub2c8\ub2e4. PD-1 \ucc28\ub2e8, FGFR \uc5b5\uc81c, ADC \uce58\ub8cc \ub4f1 \ub2e4\uc591\ud55c \ubd84\uc790\uc801 \ud2b9\uc131\uc744 \uac00\uc9c0\uace0 \uc788\uc5b4 \uc81c\uc57d \ud30c\uc774\ud504\ub77c\uc778\uc5d0 \uc5ec\ub7ec \uc0c1\uc5c5\ud654 \uacbd\ub85c\ub97c \uc81c\uacf5\ud569\ub2c8\ub2e4.<br \/>\n*   \ud3b8\ud3c9\uc0c1\ud53c\uc138\ud3ec\uc554 \ubc0f \uc120\uc554: \uc5ec\uc804\ud788 \ubbf8\uac1c\ucc99 \uc0c1\ud0dc\uc774\uba70, \ubc29\uad11\uc554 \uce58\ub8cc\uc81c \ubc0f \uc9c4\ub2e8 \uc2dc\uc7a5 \uaddc\ubaa8\uc5d0\uc11c \ucc28\uc9c0\ud558\ub294 \ube44\uc911\uc740 \ubbf8\ubbf8\ud569\ub2c8\ub2e4. \uc81c\ud55c\ub41c \uc784\uc0c1 \uc2dc\ud5d8 \ub4f1\ub85d\uacfc \uc774\uc9c8\uc801\uc778 \ubd84\uc790 \ud504\ub85c\ud30c\uc77c\uc740 \uc2e0\uc57d \uac1c\ubc1c\uc744 \ub2a6\ucd94\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>4.3. \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4: \ubcd1\uc6d0\uc774 \uce58\ub8cc\uc758 \uc911\uc2ec, ASC \ucc38\uc5ec \ud655\ub300<\/p>\n<p>*   \ubcd1\uc6d0: 2025\ub144 \uc9c0\ucd9c\uc758 53.70%\ub97c \uc720\uc9c0\ud558\uba70 \ubcf5\uc7a1\ud55c \uc808\uc81c\uc220, \uc804\uc2e0 \uce58\ub8cc \uc2dc\uc791 \ubc0f \ubd80\uc791\uc6a9 \uad00\ub9ac\ub97c \uc704\ud55c \ud5c8\ube0c \uc5ed\ud560\uc744 \ud569\ub2c8\ub2e4. \ubcd1\uc6d0\uc740 \uc9c4\ub2e8 \uacb0\uacfc\uc640 \uac1c\uc778 \ub9de\ucda4\ud615 \uce58\ub8cc \uacc4\ud68d\uc744 \uc5f0\uacc4\ud558\ub294 \ub2e4\ud559\uc81c \uc704\uc6d0\ud68c\ub97c \uc6b4\uc601\ud558\uc5ec \ubc29\uad11\uc554 \uce58\ub8cc\uc81c \ubc0f \uc9c4\ub2e8 \uc2dc\uc7a5\uc5d0\uc11c \uc911\uc2ec\uc801\uc778 \uc5ed\ud560\uc744 \uac15\ud654\ud569\ub2c8\ub2e4.<br \/>\n*   \uc678\ub798 \uc218\uc220 \uc13c\ud130 (ASCs): \ubcf4\ud5d8 \uc801\uc6a9\uc774 \ud655\ub300\ub418\uace0 \ub9ce\uc740 \ubc29\uad11\uacbd \uae30\ubc18 \uc2dc\uc220\uc758 \uc808\ucc28 \uc2dc\uac04\uc774 2\uc2dc\uac04 \ubbf8\ub9cc\uc73c\ub85c \ub2e8\ucd95\ub418\uba74\uc11c \uc2dc\uc7a5 \uaddc\ubaa8\uac00 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. ASC\ub294 \uc77c\uc815\uc744 \ucd5c\uc801\ud654\ud558\uace0 \uc785\uc6d0 \ubcd1\uc0c1 \uc218\uc694\ub97c \uc904\uc5ec \ub0ae\uc740 \uc2dc\uc124 \ube44\uc6a9\uacfc \uc9e7\uc740 \ud68c\ubcf5 \uc2dc\uac04\uc744 \ud1b5\ud574 \uc9c0\ubd88\uc790\uc640 \ud658\uc790 \ubaa8\ub450\uc5d0\uac8c \uc774\uc810\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<br \/>\n*   \uc804\ubb38 \uc13c\ud130: NIH \ubc0f EU \ubcf4\uc870\uae08\uc744 \ud655\ubcf4\ud558\uc5ec \uc911\uac1c \uc5f0\uad6c\ub97c \uc218\ud589\ud558\ub294 \ud559\uc220 \uae30\uad00\uc744 \uc911\uc2ec\uc73c\ub85c \ud615\uc131\ub418\uba70, \uc784\uc0c1 \uce58\ub8cc\uc640 \ud504\ub85c\ud1a0\ucf5c \uac1c\ubc1c\uc744 \uacb0\ud569\ud569\ub2c8\ub2e4.<\/p>\n<p>5. \uc9c0\uc5ed\ubcc4 \ubd84\uc11d<\/p>\n<p>*   \ubd81\ubbf8: 2025\ub144 \ub9e4\ucd9c\uc758 44.20%\ub97c \ucc28\uc9c0\ud558\uba70 \uc2dc\uc7a5\uc744 \uc120\ub3c4\ud588\uc2b5\ub2c8\ub2e4. \uac15\ub825\ud55c FDA \uac00\uc18d \ud504\ub85c\uadf8\ub7a8, NCCN(National Comprehensive Cancer Network) \uac00\uc774\ub4dc\ub77c\uc778 \uc5c5\ub370\uc774\ud2b8, \uccad\uc0c9\uad11 \ubc29\uad11\uacbd \ud0a4\ud2b8 \ubc0f \uc18c\ubcc0 \ubc14\uc774\uc624\ub9c8\ucee4 \uac80\uc0ac\ub97c \uc9c0\uc6d0\ud558\ub294 \uba54\ub514\ucf00\uc5b4(Medicare) \ubcf4\ud5d8 \uc801\uc6a9\uc774 \uc131\uc7a5\uc744 \uacac\uc778\ud569\ub2c8\ub2e4. \uce90\ub098\ub2e4\ub294 \uc8fc(\u5dde) \uac04 \uad6c\ub9e4 \uadf8\ub8f9\uc744 \ud65c\uc6a9\ud558\uc5ec \uc720\ub9ac\ud55c \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c \uac00\uaca9\uc744 \ud611\uc0c1\ud558\uba70, \uba55\uc2dc\ucf54\ub294 Seguro Popular \uac1c\ud601\uc744 \ud1b5\ud574 \uacf5\uacf5 \uc885\uc591\ud559 \ubcf4\uc7a5\uc744 \ud655\ub300\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591: 2031\ub144\uae4c\uc9c0 10.40%\uc758 \uac00\uc7a5 \ube60\ub978 \uc9c0\uc5ed \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc911\uad6d, \uc77c\ubcf8, \uc778\ub3c4\uac00 \uc885\uc591\ud559 \uc778\ud504\ub77c\ub97c \uc5c5\uadf8\ub808\uc774\ub4dc\ud558\uace0 \uc788\uae30 \ub54c\ubb38\uc785\ub2c8\ub2e4. \uc911\uad6d\uc758 \ud604\uc9c0 \uc81c\uc870 \ud30c\ud2b8\ub108\uc2ed\uc740 \uba74\uc5ed\uad00\ubb38\uc5b5\uc81c\uc81c\uc758 \ub2e8\uac00\ub97c \ub0ae\ucdb0 \uc9c0\ubc29 \uc554 \uc13c\ud130\uc5d0\uc11c\uc758 \ucc44\ud0dd\uc744 \ucd09\uc9c4\ud569\ub2c8\ub2e4. \uc77c\ubcf8\uc740 \uac15\ub825\ud55c \uad6d\ubbfc \uac74\uac15 \ubcf4\ud5d8 \uc801\uc6a9\uc73c\ub85c \uc5d4\ud3ec\ub974\ud22c\ub9d9 \ubca0\ub3c4\ud2f4 \ubc0f \ud3a8\ube0c\ub864\ub9ac\uc8fc\ub9d9\uc758 \ub192\uc740 \ucc44\ud0dd\ub960\uc744 \uc720\uc9c0\ud569\ub2c8\ub2e4. \uc778\ub3c4\uc758 \ubbfc\uac04 \uccb4\uc778\uc740 \uc810\ucc28 \uccad\uc0c9\uad11 \ubc29\uad11\uacbd \uac80\uc0ac\ub97c \ub3c4\uc785\ud558\uace0 \uc788\uc73c\uba70, \uad11\ubc94\uc704\ud55c \ubcf4\ud5d8 \uc801\uc6a9\uc774 \uc774\ub8e8\uc5b4\uc9c0\uae30 \uc804\uae4c\uc9c0\ub294 \uac00\ucc98\ubd84 \uc18c\ub4dd\uc774 \ub192\uc740 \ub300\ub3c4\uc2dc\ub97c \uc6b0\uc120\uc2dc\ud569\ub2c8\ub2e4. \uc2f1\uac00\ud3ec\ub974 \ubc0f \ub9d0\ub808\uc774\uc2dc\uc544\uc640 \uac19\uc740 \uc544\uc138\uc548(ASEAN) \uad6d\uac00\ub4e4\uc740 \uac00\uce58 \uae30\ubc18 \uc758\ub8cc \uc2dc\ubc94 \uc0ac\uc5c5 \ub0b4\uc5d0\uc11c AI \uae30\ubc18 \uc18c\ubcc0 \uc9c4\ub2e8 \uae30\uc220\uc744 \uc2dc\ubc94 \uc6b4\uc601\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc720\ub7fd: \uc720\ub7fd \uc758\uc57d\ud488\uccad(EMA)\uc758 \uc870\uc728\ub41c \uac80\ud1a0 \uc808\ucc28\uc640 \ube44\uc6a9-\ud3b8\uc775 \uba85\ud655\uc131\uc744 \uac15\uc870\ud558\ub294 \uad6d\uac00 \ubcf4\uac74 \uae30\uc220 \ud3c9\uac00(HTA)\uc5d0 \ud798\uc785\uc5b4 \uade0\ud615 \uc7a1\ud78c \uc131\uc7a5\uc744 \ubcf4\uc785\ub2c8\ub2e4. \ub3c5\uc77c\uc758 DRG(Diagnosis Related Group) \uc2dc\uc2a4\ud15c\uc740 \uc678\ub798 \ud328\ud0a4\uc9c0 \ub0b4\uc5d0\uc11c \uccad\uc0c9\uad11 \ubc29\uad11\uacbd \uac80\uc0ac\uc5d0 \ub300\ud55c \ubcf4\ud5d8\uc744 \uc801\uc6a9\ud558\uc5ec \uc785\uc6d0 \uae30\ubc18 \ubc29\uad11\uacbd \uac80\uc0ac\uc5d0\uc11c \ubc97\uc5b4\ub098\ub3c4\ub85d \uc7a5\ub824\ud569\ub2c8\ub2e4. \uc601\uad6d\uc758 \uc554 \uc57d\ubb3c \uae30\uae08(Cancer Drugs Fund)\uc740 \uc0c8\ub85c\uc6b4 ADCs\uc5d0 \ub300\ud55c \uc870\uac74\ubd80 \uc811\uadfc\uc744 \uac00\uc18d\ud654\ud558\ub294 \ub3d9\uc2dc\uc5d0 \uc804\uccb4 NHS(\uad6d\ubbfc \uac74\uac15 \uc11c\ube44\uc2a4) \uc790\uae08 \uc9c0\uc6d0 \uacb0\uc815\uc744 \uc704\ud55c \ub4f1\ub85d \ub370\uc774\ud130\ub97c \uc218\uc9d1\ud569\ub2c8\ub2e4. \ub0a8\uc720\ub7fd \uc2dc\uc7a5\uc740 \uacf5\ub3d9 \uc785\ucc30\uc744 \ud1b5\ud574 \uc870\ub2ec\uc744 \uc870\uc728\ud558\uc5ec \ud1b5\ud569\ub41c \ubb3c\ub7c9\uc744 \ud1b5\ud574 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c \ud560\uc778\uc744 \ud611\uc0c1\ud558\uba74\uc11c \uac00\uc774\ub4dc\ub77c\uc778\uc5d0 \uae30\ubc18\ud55c \ud601\uc2e0\uc5d0 \ub300\ud55c \uac1c\ubc29\uc801\uc778 \uc811\uadfc\uc744 \uc720\uc9c0\ud569\ub2c8\ub2e4.<\/p>\n<p>6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<p>\ubc29\uad11\uc554 \uce58\ub8cc\uc81c \ubc0f \uc9c4\ub2e8 \uc2dc\uc7a5\uc740 \ud30c\ud3b8\ud654\ub418\uc5b4 \uc788\uc2b5\ub2c8\ub2e4. \ub85c\uc288(Roche), \uba38\ud06c(Merck), \ube0c\ub9ac\uc2a4\ud1a8 \ub9c8\uc774\uc5b4\uc2a4 \uc2a4\ud045(Bristol Myers Squibb), \uc544\uc2a4\ud2b8\ub77c\uc81c\ub124\uce74(AstraZeneca)\uac00 \uba74\uc5ed \uc885\uc591\ud559 \ub9e4\ucd9c\uc744 \uc9c0\ubc30\ud558\uace0 \uc788\uc9c0\ub9cc, \uac01 \uc0ac\ub294 \ud2b9\uc815 \uc801\uc751\uc99d\uc744 \ubcf4\uc720\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc5d4\ud3ec\ub974\ud22c\ub9d9 \ubca0\ub3c4\ud2f4\uc758 \uc131\uacf5\uc740 \uc2dc\uc820(Seagen)\uacfc \ud654\uc774\uc790(Pfizer)\uac00 \ub125\ud2f4-2 \ubc0f \ub125\ud2f4-3\ub97c \ud45c\uc801\uc73c\ub85c \ud558\ub294 \ucc28\uc138\ub300 ADCs \uac1c\ubc1c\uc744 \uac00\uc18d\ud654\ud558\ub3c4\ub85d \uc790\uadf9\ud588\uc2b5\ub2c8\ub2e4. \uc804\ub7b5\uc801 \uc81c\ud734\uac00 \ud655\uc0b0\ub418\uace0 \uc788\uc73c\uba70, \uba38\ud06c\ub294 2024\ub144 \ucf08\ub8ec \ubc14\uc774\uc624\ud14d(Kelun-Biotech)\uacfc\uc758 \ud611\uc57d\uc744 \ud1b5\ud574 7\uac1c\uc758 ADC \ud6c4\ubcf4 \ubb3c\uc9c8\uc744 \uc694\ub85c\uc0c1\ud53c \ud30c\uc774\ud504\ub77c\uc778\uc5d0 \ucd94\uac00\ud588\uc2b5\ub2c8\ub2e4. \uc874\uc2a8\uc564\ub4dc\uc874\uc2a8(Johnson &#038; Johnson)\uc758 TAR-200\uc740 \uc0dd\ubd84\ud574\uc131 \ub9c1 \ub0b4\uc5d0 \uc11c\ubc29\ud615 \uc82c\uc2dc\ud0c0\ube48(gemcitabine)\uc744 \uc0bd\uc785\ud558\uc5ec \uce74\ud14c\ud130 \uc81c\uac70 \uc5c6\uc774 21\uc77c \ub3d9\uc548 \uc57d\ubb3c \uccb4\ub958 \uc2dc\uac04\uc744 \uac00\ub2a5\ud558\uac8c \ud558\uc5ec \ube44\uadfc\uce68\uc724\uc131 \uc9c8\ud658\uc5d0 \uc774\uc810\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc9c4\ub2e8 \ud601\uc2e0\uc740 \uc0c8\ub85c\uc6b4 \uc2dc\uc7a5 \uc9c4\uc785\uc790\ub97c \ucd94\uac00\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud3ec\ud1a0\ud050\uc5b4(Photocure)\uc758 Cysview \uc5fc\ub8cc\ub294 \uccad\uc0c9\uad11 \uc601\uc0c1 \ubd84\uc57c\uc5d0\uc11c \uc120\ub450 \uc8fc\uc790 \uc9c0\uc704\ub97c \uc720\uc9c0\ud558\uace0 \uc788\uc73c\uba70, \uce7c \uc2a4\ud1a8\uce20(Karl Storz)\uc640 \uc62c\ub9bc\ud478\uc2a4(Olympus)\ub294 \ud615\uad11 \ud544\ud130\uc640 \ud638\ud658\ub418\uc9c0 \uc54a\ub294 4K \uae30\uc220\ub85c \uacbd\uc7c1\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. AI \uc2a4\ud0c0\ud2b8\uc5c5\uc740 \uc18c\ubcc0 \ubc14\uc774\uc624\ub9c8\ucee4 \ubd84\ub958\uae30\ub97c \uc9c0\uc5ed \uc2e4\ud5d8\uc2e4\uc5d0 \ub77c\uc774\uc120\uc2a4\ud558\uc5ec \ud655\uc7a5 \uac00\ub2a5\ud558\uace0 \ud50c\ub7ab\ud3fc\uc5d0 \uad6c\uc560\ubc1b\uc9c0 \uc54a\ub294 \uc81c\ud488\uc744 \ub9cc\ub4e4\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uacbd\uc7c1 \uad6c\ub3c4\ub294 \ud14c\uc2a4\ud2b8 \uacb0\uacfc\uc640 \uce58\ub8cc \uc120\ud0dd\uc744 \uc5f0\uacb0\ud558\ub294 \ubc88\ub4e4 \uc194\ub8e8\uc158\uc744 \uac15\uc870\ud558\uba70, \uc758\uc0ac \uacb0\uc815 \uc8fc\uae30\ub97c \ub2e8\ucd95\ud558\uace0 \uc870\ub2ec \uc785\ucc30\uc5d0\uc11c \uacf5\uae09\uc5c5\uccb4\ub97c \ucc28\ubcc4\ud654\ud569\ub2c8\ub2e4. \uc9c0\uc801 \uc7ac\uc0b0 \ud3ec\ud2b8\ud3f4\ub9ac\uc624\ub294 \uc7a5\uce58-\uc57d\ubb3c \uc870\ud569 \ubc0f \uc54c\uace0\ub9ac\uc998 \uc758\uc0ac \uacb0\uc815 \uc9c0\uc6d0\uc744 \uac15\uc870\ud558\uba70, \uc18c\ud504\ud2b8\uc6e8\uc5b4, \ud558\ub4dc\uc6e8\uc5b4 \ubc0f \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c\uc758 \uc735\ud569\uc744 \ubc18\uc601\ud569\ub2c8\ub2e4.<\/p>\n<p>\ud22c\uc790\uc790\ub4e4\uc740 \uce58\ub8cc \ubc0f \uc9c4\ub2e8 \ubcf4\ud5d8 \uc801\uc6a9 \uad6c\uc870\ub97c \ubaa8\ub450 \ud0d0\uc0c9\ud560 \uc218 \uc788\ub294 \uae30\uc5c5\uc744 \uc120\ud638\ud569\ub2c8\ub2e4. \uc0ac\ubaa8\ud380\ub4dc \uadf8\ub8f9\uc740 \uccad\uc0c9\uad11 \uc2a4\uc704\ud2b8\ub97c \uac16\ucd98 ASC \uccb4\uc778\uc744 \uc778\uc218\ud558\uc5ec \uc608\uce21 \uac00\ub2a5\ud55c \ub9e4\ucd9c \uc131\uc7a5\uacfc \ud1b5\ud569 \uc2dc\ub108\uc9c0\uc5d0 \ud22c\uc790\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud55c\ud3b8, \ub300\ud615 \uc81c\uc57d\uc0ac\ub4e4\uc740 \ucd08\uae30 \ub2e8\uacc4 \ubc14\uc774\uc624\ud14d \ud30c\ud2b8\ub108\uc640 \uc635\uc158 \uad6c\ub9e4 \uc870\ud56d\uc744 \ud655\ubcf4\ud558\uc5ec \ud30c\uc774\ud504\ub77c\uc778 \uc704\ud5d8\uc744 \ud5e4\uc9c0\ud558\uace0, \uc120\ud589 \ud1b5\ud569 \ube44\uc6a9 \uc5c6\uc774 \ud68d\uae30\uc801\uc778 \uacfc\ud559 \uae30\uc220\uc5d0 \uc811\uadfc\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \ucc38\uc5ec \uae30\uc5c5:<\/p>\n<p>*   Bristol-Myers Squibb Company<br \/>\n*   GlaxoSmithKline PLC<br \/>\n*   Merck &#038; Co. Inc.<br \/>\n*   Johnson &#038; Johnson (Janssen)<br \/>\n*   F. Hoffmann-La Roche Ltd<\/p>\n<p>7. \ucd5c\uadfc \uc0b0\uc5c5 \ub3d9\ud5a5<\/p>\n<p>*   2025\ub144 7\uc6d4: \uc544\uc2a4\ud2b8\ub77c\uc81c\ub124\uce74(AstraZeneca)\ub294 \uad6d\uc18c \uc9c4\ud589\uc131 \ub610\ub294 \uc804\uc774\uc131 \uc694\ub85c\uc0c1\ud53c\uc554\uc758 1\ucc28 \uce58\ub8cc\uc81c\ub85c \uc82c\uc2dc\ud0c0\ube48 \ubc0f \uc2dc\uc2a4\ud50c\ub77c\ud2f4\uacfc \ubcd1\uc6a9\ud558\ub294 \ub354\ubc1c\ub8e8\ub9d9(Imfinzi)\uc5d0 \ub300\ud574 \uc720\ub7fd \uc704\uc6d0\ud68c \uc2b9\uc778\uc744 \ubc1b\uc558\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 2\uc6d4: \uc2dc\uc820(Seagen)\uacfc \ud654\uc774\uc790(Pfizer)\ub294 EV-302\/KEYNOTE-A39 \uc784\uc0c1 \uc2dc\ud5d8\uc5d0\uc11c \uc5d4\ud3ec\ub974\ud22c\ub9d9 \ubca0\ub3c4\ud2f4\uacfc \ud3a8\ube0c\ub864\ub9ac\uc8fc\ub9d9 \ubcd1\uc6a9 \uc694\ubc95\uc774 \ud654\ud559\uc694\ubc95\uc758 15.9\uac1c\uc6d4 \ub300\ube44 33.8\uac1c\uc6d4\uc758 \uc911\uc559 \uc804\uccb4 \uc0dd\uc874\uc728\uc744 \ub2ec\uc131\ud558\uba70 \uc804\ub840 \uc5c6\ub294 \ub0b4\uad6c\uc131 \ub370\uc774\ud130\ub97c \ubcf4\uace0\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2024\ub144 12\uc6d4: \uc720\ub85c\uc820 \ud30c\ub9c8(UroGen Pharma)\ub294 \uc800\ub4f1\uae09 \uc0c1\ubd80 \uc694\ub85c\uc0c1\ud53c\uc554 \uce58\ub8cc\ub97c \uc704\ud55c UGN-102(\ubbf8\ud1a0\ub9c8\uc774\uc2e0 \uc824)\uc758 \uae0d\uc815\uc801\uc778 3\uc0c1 \uc784\uc0c1 \uacb0\uacfc\ub97c \ubc1c\ud45c\ud588\uc73c\uba70, \uc644\uc804 \uad00\ud574\uc728\uc774 \uaddc\uc81c \uc11c\ub958 \uc900\ube44\ub97c \ub4b7\ubc1b\uce68\ud569\ub2c8\ub2e4.<br \/>\n*   2024\ub144 12\uc6d4: CG \uc628\ucf5c\ub85c\uc9c0(CG Oncology)\ub294 BCG \ubd88\uc751\uc131 \ube44\uadfc\uce68\uc724\uc131 \ubc29\uad11\uc554\uc744 \ud45c\uc801\uc73c\ub85c \ud558\ub294 \uc885\uc591 \uc6a9\ud574\uc131 \uba74\uc5ed\uc694\ubc95\uc81c CG0070\uc5d0 \ub300\ud55c 3\uc0c1 BOND-003 \uc784\uc0c1 \uc2dc\ud5d8\uc744 \uc2dc\uc791\ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \ubc29\uad11\uc554 \uce58\ub8cc\uc81c \ubc0f \uc9c4\ub2e8 \uc2dc\uc7a5\uc758 \ud604\uc7ac \uc0c1\ud669\uacfc \ubbf8\ub798 \uc804\ub9dd\uc5d0 \ub300\ud55c \ud3ec\uad04\uc801\uc778 \uc774\ud574\ub97c \uc81c\uacf5\ud558\uba70, \uad00\ub828 \uc0b0\uc5c5 \ucc38\uc5ec\uc790\ub4e4\uc5d0\uac8c \uadc0\uc911\ud55c \ud1b5\ucc30\ub825\uc744 \uc81c\uacf5\ud560 \uac83\uc785\ub2c8\ub2e4.<\/p>\n<p>\ubc29\uad11\uc554 \uce58\ub8cc \ubc0f \uc9c4\ub2e8 \uc2dc\uc7a5 \ubcf4\uace0\uc11c\ub294 \ubc29\uad11 \uc138\ud3ec\uc5d0\uc11c \uc2dc\uc791\ub418\uc5b4 \ubc29\uad11 \ub0b4\ubcbd\uc744 \ub118\uc5b4 \uadfc\uc721\ubcbd\uc73c\ub85c \ud655\uc0b0\ub420 \uc218 \uc788\ub294 \ubc29\uad11\uc554\uc758 \uc815\uc758\uc640 \ud568\uaed8, \uc2dc\uc7a5 \uac00\uc815 \ubc0f \uc5f0\uad6c \ubc94\uc704\ub97c \ub2e4\ub8e8\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubcf8 \ubcf4\uace0\uc11c\ub294 \ubc29\uad11\uc554 \uce58\ub8cc\uc81c \ubc0f \uc9c4\ub2e8 \uc2dc\uc7a5\uc758 \uac00\uce58(USD \ubc31\ub9cc)\ub97c \ucd94\uc815\ud558\uba70, \uc81c\ud488, \uc554 \uc720\ud615, \ucd5c\uc885 \uc0ac\uc6a9\uc790 \ubc0f \uc9c0\uc5ed\ubcc4\ub85c \uc2dc\uc7a5\uc744 \uc138\ubd84\ud654\ud558\uc5ec \ubd84\uc11d\ud569\ub2c8\ub2e4.<\/p>\n<p>2026\ub144 \uae30\uc900 \ubc29\uad11\uc554 \uce58\ub8cc \ubc0f \uc9c4\ub2e8 \uc2dc\uc7a5 \uaddc\ubaa8\ub294 52\uc5b5 2\ucc9c\ub9cc \ub2ec\ub7ec\ub85c \ucd94\uc815\ub429\ub2c8\ub2e4. \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uacac\uc778\ud558\ub294 \uc8fc\uc694 \ub3d9\uc778\uc73c\ub85c\ub294 \uae00\ub85c\ubc8c \ubc29\uad11\uc554 \ubc1c\ubcd1\ub960 \uc99d\uac00, \uba74\uc5ed\uad00\ubb38\uc5b5\uc81c\uc81c(Immune-Checkpoint Inhibitors) \ubc0f \ud56d\uccb4-\uc57d\ubb3c \uc811\ud569\uccb4(ADCs)\uc640 \uac19\uc740 \uc2e0\uaddc \uce58\ub8cc\uc81c\uc758 \uc2e0\uc18d\ud55c \uc2b9\uc778, \ube14\ub8e8\ub77c\uc774\ud2b8 \ubc0f 4K \ubc29\uad11\uacbd \uac80\uc0ac\uc758 \uad11\ubc94\uc704\ud55c \ucc44\ud0dd, AI \uae30\ubc18 \uc18c\ubcc0 \ubc14\uc774\uc624\ub9c8\ucee4 \uc54c\uace0\ub9ac\uc998\uc758 \ubc1c\uc804, \uc678\ub798 \uc218\uc220 \uc13c\ud130(ASC) \uae30\ubc18 \ubc29\uad11\uacbd \uac80\uc0ac\ub7c9 \uc99d\uac00, \uadf8\ub9ac\uace0 \uc7ac\ucda9\uc804 \uac00\ub2a5\ud55c \ubc29\uad11 \ub0b4 \uc57d\ubb3c \uc804\ub2ec \uc7a5\uce58 \uac1c\ubc1c \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4. \ud2b9\ud788, \uba74\uc5ed\uce58\ub8cc \ubd84\uc57c\ub294 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 8.25%\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, \uc678\ub798 \uc218\uc220 \uc13c\ud130\ub294 \uc5f0\ud3c9\uade0 7.65%\uc758 \uc131\uc7a5\uc744 \uae30\ub85d\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. AI \uae30\uc220\uc740 \ube44\uce68\uc2b5\uc801 \uac10\uc2dc\ub97c \uc81c\uacf5\ud558\uc5ec \ubc29\uad11\uacbd \uac80\uc0ac\uc5d0 \ub300\ud55c \uc758\uc874\ub3c4\ub97c \uc904\uc774\uace0 \ud658\uc790 \uc21c\uc751\ub3c4\ub97c \ud5a5\uc0c1\uc2dc\ud0ac \uc7a0\uc7ac\ub825\uc744 \uac00\uc9c0\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubc18\uba74, \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc81c\uc57d \uc694\uc778\uc73c\ub85c\ub294 \uc8fc\uc694 \ud654\ud559\uc694\ubc95 \uc57d\ubb3c\uc758 \ud2b9\ud5c8 \ub9cc\ub8cc \ubc0f \uc81c\ub124\ub9ad \uce68\uc2dd, \uc2e0\uaddc \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c\uc758 \ub192\uc740 \ube44\uc6a9 \ubc0f \uc0c1\ud658 \uc7a5\ubcbd, BCG(Bacillus Calmette-Gu\u00e9rin) \ubc31\uc2e0 \uae00\ub85c\ubc8c \ubd80\uc871\uc73c\ub85c \uc778\ud55c \uce58\ub8cc \ud328\ud134 \ud63c\ub780, \uadf8\ub9ac\uace0 \uc751\uae09 \uc758\ub8cc \uc11c\ube44\uc2a4(EMS)\uc5d0\uc11c\uc758 \ube14\ub8e8\ub77c\uc774\ud2b8 \uc7a5\ube44 \uac00\uc6a9\uc131 \uc81c\ud55c \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4. \uc2e0\ud765 \uc2dc\uc7a5\uc5d0\uc11c\ub294 \ub192\uc740 \ucd08\uae30 \ube44\uc6a9\uacfc \uc5c4\uaca9\ud55c \uc0c1\ud658 \uae30\uc900\uc774 \uc2e0\uaddc \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c \uc811\uadfc\uc744 \uc81c\ud55c\ud558\uace0 \uc788\uc73c\ub098, \uc774\ub97c \ud574\uacb0\ud558\ub824\ub294 \ub178\ub825\uc774 \uc2dc\uc791\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uc2dc\uc7a5\uc744 \uc81c\ud488(\uce58\ub8cc\uc81c: \ud654\ud559\uc694\ubc95, \uba74\uc5ed\uc694\ubc95, \ud56d\uccb4-\uc57d\ubb3c \uc811\ud569\uccb4, \ubc29\uad11 \ub0b4 \uc57d\ubb3c \uc804\ub2ec \uc7a5\uce58; \uc9c4\ub2e8: \ubc29\uad11\uacbd \uac80\uc0ac, \ubc29\uad11 \ucd08\uc74c\ud30c \ubc0f \uc601\uc0c1, \uc18c\ubcc0 \uac80\uc0ac \ubc0f \uc561\uccb4 \uc0dd\uac80 \ubc14\uc774\uc624\ub9c8\ucee4 \ud328\ub110 \ub4f1), \uc554 \uc720\ud615(\uc694\ub85c\uc0c1\ud53c\uc554, \ud3b8\ud3c9 \uc138\ud3ec\uc554, \uc120\uc554 \ub4f1), \ucd5c\uc885 \uc0ac\uc6a9\uc790(\ubcd1\uc6d0, \uc678\ub798 \uc218\uc220 \uc13c\ud130, \uc804\ubb38 \uc13c\ud130, \ud559\uc220 \ubc0f \uc5f0\uad6c \uae30\uad00) \ubc0f \uc9c0\uc5ed\ubcc4\ub85c \uc138\ubd84\ud654\ud558\uc5ec \ubd84\uc11d\ud569\ub2c8\ub2e4. \ud2b9\ud788 \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 \uc778\ud504\ub77c \uac1c\uc120 \ubc0f \uc778\uad6c \ud1b5\uacc4\ud559\uc801 \ucd94\uc138\uc5d0 \ud798\uc785\uc5b4 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 10.40%\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd \ubd84\uc11d\uc5d0\ub294 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4, \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d, \uadf8\ub9ac\uace0 F. Hoffmann-La Roche Ltd, Merck &#038; Co. Inc., Bristol-Myers Squibb Company, Pfizer Inc., Johnson &#038; Johnson (Janssen), Novartis AG, AstraZeneca PLC \ub4f1 \uc8fc\uc694 \uae00\ub85c\ubc8c \uae30\uc5c5\ub4e4\uc758 \ud504\ub85c\ud544\uc774 \ud3ec\ud568\ub429\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-54207","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/54207"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=54207"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/54207\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=54207"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=54207"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=54207"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}